Accel has 58 tracked deals to Atlas Venture's 23. Stage focus, check size, and sector fit compared side by side.
Accel is an active investor with 58 tracked deals. Atlas Venture is an active investor with 23 tracked deals. Accel shows 35 more tracked rounds than Atlas Venture in this dataset, which is the clearest signal of deployment pace between the two. Recent tracked names include Alyssum Therapeutics and Anysphere for Accel and AAVantgarde Bio and Affinia Therapeutics for Atlas Venture.
Investors like Accel · Investors like Atlas Venture · Accel co-investors · Full investor directory